South Korea Radiopharmaceuticals Market to 2032
Overview
The South Korea Radiopharmaceuticals Market is expected to reach a 362.47 USD Billion by 2032 and is projected to grow at a CAGR of 7.91% from 2025 to 2032.
Revenue, 2024 (USD Billion)
236.26
Forecast, 2032 (USD Billion)
362.47
CAGR, 2024 - 2032
7.91%
Report Coverage
South Korea
South Korea Radiopharmaceuticals Market 2018-2032 USD Billion
South Korea Radiopharmaceuticals Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 236.26 USD Billion
- Projected Market Size (2032): 362.47 USD Billion
- CAGR (2025-2032): 7.91%
Key Findings of South Korea Radiopharmaceuticals Market
- The South Korea Radiopharmaceuticals Market was valued at 362.47 USD Billion in 2024.
- The South Korea Radiopharmaceuticals Market is likely to grow at a CAGR of 7.91% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Nuclear Reactors in By Source Segment accounted for the largest share of the market with a revenue of 140.11 USD Billion
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 8.66% during the forecast period from 2024 to 2032.
South Korea Radiopharmaceuticals Market Scope
South Korea Radiopharmaceuticals Market Segmentation & Scope
By Type
- Therapeutic Radiopharmaceuticals
- Diagnostic Radiopharmaceuticals
By Application
- Therapeutic
- Diagnostic
By Source
- Cyclotrons
- Nuclear Reactors
End User
- Others
- Ambulatory Surgical Centers
- Cancer Research Institutes
- Diagnostic Centers
- Hospitals
South Korea Radiopharmaceuticals Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 236.26 USD Billion |
| Market Value in 2032 | 362.47 USD Billion |
| CAGR (2025-2032) | 7.91% |
| Historic Data | 2016-2023 |
| Market Segments Covered | By Type,By Application,By Source,End User |
Regional Insights:
-
Leading Market (2024-2032): South Korea, leading in terms of revenue 236.26 USD Billion in 2024
- Key Country: South Korea, leading in terms of revenue with value of 236.26 USD Billion in 2024.
Segments and Scope
-
South Korea Radiopharmaceuticals Market to 2032, By By Type
- Diagnostic Radiopharmaceuticals is the largest segment in South Korea Radiopharmaceuticals Market to 2032 with a revenue of 132.46 USD Billion in the year 2024.
- Diagnostic Radiopharmaceuticals is the Fastest growing segment in South Korea Radiopharmaceuticals Market to 2032 with a Growth rate of 8.42 % in forecast period 2025-2032.
-
South Korea Radiopharmaceuticals Market to 2032, By By Application
- Diagnostic is the largest segment in South Korea Radiopharmaceuticals Market to 2032 with a revenue of 126.21 USD Billion in the year 2024.
- Diagnostic is the Fastest growing segment in South Korea Radiopharmaceuticals Market to 2032 with a Growth rate of 8.46 % in forecast period 2025-2032.
-
South Korea Radiopharmaceuticals Market to 2032, By By Source
- Nuclear Reactors is the largest segment in South Korea Radiopharmaceuticals Market to 2032 with a revenue of 140.11 USD Billion in the year 2024.
- Nuclear Reactors is the Fastest growing segment in South Korea Radiopharmaceuticals Market to 2032 with a Growth rate of 8.34 % in forecast period 2025-2032.
-
South Korea Radiopharmaceuticals Market to 2032, By End User
- Hospitals is the largest segment in South Korea Radiopharmaceuticals Market to 2032 with a revenue of 89.13 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in South Korea Radiopharmaceuticals Market to 2032 with a Growth rate of 8.66 % in forecast period 2025-2032.
South Korea Radiopharmaceuticals Market Company Share Analysis
| Company Name |
|
||
| Cardinal Health | |||
| Advanced Accelerator Applications, A Novartis Company | |||
| GE HealthCare | |||
| Lantheus | |||
| Curium and its affiliates | |||
South Korea Radiopharmaceuticals Market Geographical Sales Distribution, 2018-2032 USD Billion
South Korea Radiopharmaceuticals Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South Korea Radiopharmaceuticals Market is segmented based on Segmentation By Type,By Application,By Source,End User.
South Korea Radiopharmaceuticals Market was valued at USD 236.26(Revenue in USD Billion) in 2021.
South Korea Radiopharmaceuticals Market is projected to grow at a CAGR of 7.91% during the forecast period of 2024 to 2032.
The Nuclear Reactors segment is expected to dominate the South Korea Radiopharmaceuticals Market, holding a largest market share of 140.11 USD Billion in 2024
South Korea Radiopharmaceuticals Market Scope
South Korea Radiopharmaceuticals Market Segmentation & Scope
By Type
- Therapeutic Radiopharmaceuticals
- Diagnostic Radiopharmaceuticals
By Application
- Therapeutic
- Diagnostic
By Source
- Cyclotrons
- Nuclear Reactors
End User
- Others
- Ambulatory Surgical Centers
- Cancer Research Institutes
- Diagnostic Centers
- Hospitals
Frequently Asked Questions
The South Korea Radiopharmaceuticals Market is segmented based on Segmentation By Type,By Application,By Source,End User.
South Korea Radiopharmaceuticals Market was valued at USD 236.26(Revenue in USD Billion) in 2021.
South Korea Radiopharmaceuticals Market is projected to grow at a CAGR of 7.91% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Radiopharmaceuticals Market for final year is USD 362.47 (USD Billion).
South Korea Radiopharmaceuticals Market Company Profiling
Frequently Asked Questions
The South Korea Radiopharmaceuticals Market is segmented based on Segmentation By Type,By Application,By Source,End User.
South Korea Radiopharmaceuticals Market was valued at USD 236.26(Revenue in USD Billion) in 2021.
South Korea Radiopharmaceuticals Market is projected to grow at a CAGR of 7.91% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Radiopharmaceuticals Market for final year is USD 362.47 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.